|
US2020291423A1
|
|
Mammalian expression system
|
|
CN105849265A
|
|
Means and methods for the generation of mammalian producer cells for the production of recombinant proteins
|
|
HUE026516T2
|
|
Expression vectors comprising chimeric cytomegalovirus promoter and enhancer sequences
|
|
EP2711428A1
|
|
Site-specific integration
|
|
JP2011092196A
|
|
Method for expressing recombinant protein in cho cell
|
|
EP2447717A1
|
|
Rapid method for targeted cell (line) selection
|
|
NZ598381A
|
|
Method and system for polypeptide purification
|
|
KR20120046738A
|
|
Deepwell plate system with lid
|
|
JP2010042006A
|
|
Method for expressing recombinant protein in cho cell
|
|
GB0914691D0
|
|
Immunoglobulin variants
|
|
WO2009135656A1
|
|
A method for the purification of antibodies using displacement chromatography
|
|
EP2216395A1
|
|
Bioreactor for the cultivation of mammalian cells
|
|
SG173405A1
|
|
Method for predicting protein aggregation and designing aggregation inhibitors
|
|
GB0710614D0
|
|
Mammalian expression vector with a highly efficient secretory signal sequence
|
|
AU2007202087A1
|
|
Glutamine-auxothrophic human cells capable of producing proteins and capable of growing in a glutamine-free medium
|
|
CA2606576A1
|
|
High-level expression of recombinant antibody in a mammalian host cell
|
|
CA2600986A1
|
|
Mammalian expression vector comprising the mcmv promoter and first intron of hcmv major immediate early gene
|
|
GB0526372D0
|
|
High-level expression of recombinant antibody in a mammalian host cell
|
|
AU2005279347A1
|
|
Affinity- plus ion exchange- chromatography for purifying antibodies
|
|
CN101120017A
|
|
Affinity-plus ion exchange-chromatography for purifying antibodies
|
